Concepedia
Statistics
Publications
13
Citations
1.2K
H-Index
12
Active since
1987
Affiliations
GlaxoSmithKline (United Kingdom)(Current)
Research Triangle Park Foundation
GlaxoSmithKline (United States)
University of North Carolina at Chapel Hill
Age UK
Linda P. Briley is an author at GlaxoSmithKline (United Kingdom) specializing in genetics, life sciences, and medicine.
Publications per year
1987–2017
The Population Reference Sample, POPRES: A Resource for Population, Disease, and Pharmacological Genetics Research
Matthew R. Nelson, Katarzyna Bryc, Karen S. King et al. · The American Journal of Human Genetics · 2008 · 334 citations · Full text
Life Sciences, Genetics, Molecular Genetics +14
<i>HLA-DQA1</i> * <i>02:01</i> Is a Major Risk Factor for Lapatinib-Induced Hepatotoxicity in Women With Advanced Breast Cancer
Colin F. Spraggs, L. R. Budde, Linda P. Briley et al. · Journal of Clinical Oncology · 2011 · 277 citations
Medicine, Genetics, Oncology +17
Genomewide Search for Type 2 Diabetes Susceptibility Genes in Four American Populations
Margaret G. Ehm, Maha Karnoub, H. Sakul et al. · The American Journal of Human Genetics · 2000 · 196 citations · Full text
Life Sciences, Genetics, Molecular Genetics +15
<i>HLA-B</i> *57:01 Confers Susceptibility to Pazopanib-Associated Liver Injury in Patients with Cancer
Chun‐Fang Xu, Toby Johnson, Xiaojing Wang et al. · Clinical Cancer Research · 2015 · 95 citations · Full text
Medicine, Oncology, Pharmacology +16
Comprehensive genome-wide evaluation of lapatinib-induced liver injury yields a single genetic signal centered on known risk allele HLA-DRB1*07:01
Laura R. Parham, Linda P. Briley, L Li et al. · The Pharmacogenomics Journal · 2015 · 63 citations · Full text
Life Sciences, Genetics, Immunology +17
1–5 of 13